Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation.

Loeffler J, Steffens M, Arlt EM, Toliat MR, Mezger M, Suk A, Wienker TF, Hebart H, Nürnberg P, Boeckh M, Ljungman P, Trenschel R, Einsele H.

J Clin Microbiol. 2006 May;44(5):1847-50.

2.

Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patients according to single nucleotide polymorphisms in donor and recipient CCR5, MCP-1, IL-10, and TLR9 genes.

Corrales I, Giménez E, Solano C, Amat P, de la Cámara R, Nieto J, Garcia-Noblejas A, Navarro D.

J Med Virol. 2015 Feb;87(2):248-55. doi: 10.1002/jmv.24050. Epub 2014 Aug 17.

PMID:
25132583
3.

Investigation of promoter variations in dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN) (CD209) and their relevance for human cytomegalovirus reactivation and disease after allogeneic stem-cell transplantation.

Mezger M, Steffens M, Semmler C, Arlt EM, Zimmer M, Kristjanson GI, Wienker TF, Toliat MR, Kessler T, Einsele H, Loeffler J.

Clin Microbiol Infect. 2008 Mar;14(3):228-34. Epub 2007 Dec 8.

4.

Looking for biological factors to predict the risk of active cytomegalovirus infection in non-immunosuppressed critically ill patients.

Bravo D, Clari MA, Aguilar G, Belda J, Giménez E, Carbonell JA, Henao L, Navarro D.

J Med Virol. 2014 May;86(5):827-33. doi: 10.1002/jmv.23838. Epub 2013 Nov 5.

PMID:
24431153
5.

Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies.

Ozdemir E, Saliba RM, Champlin RE, Couriel DR, Giralt SA, de Lima M, Khouri IF, Hosing C, Kornblau SM, Anderlini P, Shpall EJ, Qazilbash MH, Molldrem JJ, Chemaly RF, Komanduri KV.

Bone Marrow Transplant. 2007 Jul;40(2):125-36. Epub 2007 May 28.

PMID:
17530009
6.

Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation.

Carvalho A, Cunha C, Carotti A, Aloisi T, Guarrera O, Di Ianni M, Falzetti F, Bistoni F, Aversa F, Pitzurra L, Rodrigues F, Romani L.

Exp Hematol. 2009 Sep;37(9):1022-9. doi: 10.1016/j.exphem.2009.06.004. Epub 2009 Jun 17.

PMID:
19539691
7.

The presence of functional CCR5 and EBV reactivation after allogeneic haematopoietic stem cell transplantation.

Bogunia-Kubik K, Jaskula E, Lange A.

Bone Marrow Transplant. 2007 Jul;40(2):145-50. Epub 2007 May 28.

PMID:
17530006
8.

A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low-, intermediate-, and high-risk groups: reactivation risk is increased by graft-versus-host disease only in the intermediate-risk group.

George B, Kerridge IH, Gilroy N, Huang G, Hertzberg MS, Bradstock KF, Gottlieb DJ.

Transpl Infect Dis. 2012 Apr;14(2):141-8. doi: 10.1111/j.1399-3062.2011.00706.x. Epub 2012 Jan 29.

PMID:
22283838
9.

Cytomegalovirus reactivation after matched sibling donor reduced-intensity conditioning allogeneic hematopoietic stem cell transplant correlates with donor killer immunoglobulin-like receptor genotype.

Sobecks RM, Askar M, Thomas D, Rybicki L, Kalaycio M, Dean R, Avery R, Mossad S, Copelan E, Bolwell BJ.

Exp Clin Transplant. 2011 Feb;9(1):7-13.

10.

The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.

Kucukgergin C, Isman FK, Dasdemir S, Cakmakoglu B, Sanli O, Gokkusu C, Seckin S.

Gene. 2012 Dec 10;511(1):7-11. doi: 10.1016/j.gene.2012.09.011. Epub 2012 Sep 14.

PMID:
22982413
11.

Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation.

Seo KW, Kim DH, Sohn SK, Lee NY, Chang HH, Kim SW, Jeon SB, Baek JH, Kim JG, Suh JS, Lee KB.

Bone Marrow Transplant. 2005 Dec;36(12):1089-95.

PMID:
16247433
12.

Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation.

Borchers S, Luther S, Lips U, Hahn N, Kontsendorn J, Stadler M, Buchholz S, Diedrich H, Eder M, Koehl U, Ganser A, Mischak-Weissinger E.

Transpl Infect Dis. 2011 Jun;13(3):222-36. doi: 10.1111/j.1399-3062.2011.00626.x. Epub 2011 May 18.

PMID:
21585633
13.

Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation.

Sacre K, Nguyen S, Deback C, Carcelain G, Vernant JP, Leblond V, Autran B, Dhedin N.

J Virol. 2008 Oct;82(20):10143-52. doi: 10.1128/JVI.00688-08. Epub 2008 Aug 6.

14.

Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.

George B, Pati N, Gilroy N, Ratnamohan M, Huang G, Kerridge I, Hertzberg M, Gottlieb D, Bradstock K.

Transpl Infect Dis. 2010 Aug 1;12(4):322-9. doi: 10.1111/j.1399-3062.2010.00504.x. Epub 2010 May 11.

PMID:
20487414
15.

Cytomegalovirus-specific CD4 T-cell and glycoprotein B specific antibody response in recipients of allogenic stem cell transplantation.

Ludwig B, Kraus FB, Kipp M, Preiser W, Schwerdtfeger R, Doerr HW, Buxbaum S.

J Clin Virol. 2006 Feb;35(2):160-6. Epub 2005 Aug 19.

PMID:
16112610
16.

Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.

Hebart H, Rudolph T, Loeffler J, Middeldorp J, Ljubicic T, Jahn G, Einsele H.

Bone Marrow Transplant. 2002 Aug;30(3):181-7.

17.

Saliva as a source of HCMV DNA in allogeneic stem cell transplantation patients.

Correia-Silva JF, Bruna-Romero O, Resende RG, Miranda LP, Oliveira FE, Costa FO, Xavier SG, Figueiredo-Neves SP, Almeida HC, Bittencourt H, Gomez RS.

Oral Dis. 2010 Mar;16(2):210-6. doi: 10.1111/j.1601-0825.2009.01637.x.

PMID:
20374507
18.

HCMV gB genotype and its association with cytokine levels in hematopoietic stem cell transplantation.

Correia-Silva JF, Resende RG, Arão TC, Abreu MH, Teixeira MM, Bittencourt H, Silva TA, Gomez RS.

Oral Dis. 2011 Jul;17(5):530-7. doi: 10.1111/j.1601-0825.2011.01801.x. Epub 2011 Feb 18.

PMID:
21332604
19.

Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians.

Ahluwalia TS, Khullar M, Ahuja M, Kohli HS, Bhansali A, Mohan V, Venkatesan R, Rai TS, Sud K, Singal PK.

PLoS One. 2009;4(4):e5168. doi: 10.1371/journal.pone.0005168. Epub 2009 Apr 9.

20.

Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.

Lilleri D, Fornara C, Chiesa A, Caldera D, Alessandrino EP, Gerna G.

Haematologica. 2008 Feb;93(2):248-56. doi: 10.3324/haematol.11912.

Supplemental Content

Support Center